BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34712325)

  • 1. A Novel S100 Family-Based Signature Associated with Prognosis and Immune Microenvironment in Glioma.
    Hu Y; Song J; Wang Z; Kan J; Ge Y; Wang D; Zhang R; Zhang W; Liu Y
    J Oncol; 2021; 2021():3586589. PubMed ID: 34712325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illustrating the biological functions and diagnostic value of transmembrane protein family members in glioma.
    Zhang Y; Zhang W; Yuan Q; Hong W; Yin P; Shen T; Fang L; Jiang J; Shi F; Chen W
    Front Oncol; 2023; 13():1145676. PubMed ID: 37064154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients.
    Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J
    Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma.
    Jiang C; Zhou Y; Yan L; Zheng J; Wang X; Li J; Jiang X
    Front Oncol; 2023; 13():1051641. PubMed ID: 36845744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of HDAC Family Identifies
    Fan Y; Peng X; Wang Y; Li B; Zhao G
    Front Mol Biosci; 2021; 8():720020. PubMed ID: 34540896
    [No Abstract]   [Full Text] [Related]  

  • 9. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
    He Y; Ye Y; Tian W; Qiu H
    Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
    [No Abstract]   [Full Text] [Related]  

  • 10. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
    Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X
    Front Oncol; 2021; 11():682932. PubMed ID: 34123852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Guo F; Hong J
    Front Genet; 2020; 11():441. PubMed ID: 32431729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel disulfide death-related genes prognostic signature identifies the role of IPO4 in glioma progression.
    Wu H; Yang Z; Chang C; Wang Z; Zhang D; Guo Q; Zhao B
    Cancer Cell Int; 2024 May; 24(1):168. PubMed ID: 38734657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constructing a signature based on the SIRT family to help the prognosis and treatment sensitivity in glioma patients.
    Xuan F; Zhang Z; Liu K; Gong H; Liang S; Zhao Y; Li H
    Front Genet; 2022; 13():1035368. PubMed ID: 36568393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
    Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
    Liu YQ; Wu F; Li JJ; Li YF; Liu X; Wang Z; Chai RC
    Front Oncol; 2019; 9():1433. PubMed ID: 31921684
    [No Abstract]   [Full Text] [Related]  

  • 17. Alarm Signal S100-Related Signature Is Correlated with Tumor Microenvironment and Predicts Prognosis in Glioma.
    Wang LJ; Lv P; Lou Y
    Dis Markers; 2022; 2022():4968555. PubMed ID: 35592707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
    Chen Z; Wu T; Yan Z; Zhang M
    Front Cell Dev Biol; 2021; 9():652599. PubMed ID: 34249910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
    Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
    J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a Prognostic Gene Signature Associated with Immune Infiltration in Glioma: A Comprehensive Analysis Based on the CGGA.
    Gong X; Liu L; Xiong J; Li X; Xu J; Xiao Y; Li J; Luo X; Mao D; Liu L
    J Oncol; 2021; 2021():6620159. PubMed ID: 33790966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.